BioHelix

This article has been updated from a previous version to correct the spelling of Quidel's AmpliVue technology.
By Ben Butkus

By a GenomeWeb staff reporter


NEW YORK (GenomeWeb News) – BioHelix today announced that the US Food and Drug Administration has given 510(k) clearance for its assay for the detection of herpes simplex virus.

Quidel recently submitted a 510(k) package to the US Food and Drug Administration for its first molecular diagnostic assay, a real-time PCR-based test for influenza A and B for use on Life Technologies' 7500 Fast Dx platform.

The key to the system is helicase-dependent amplification — an isothermal amplification method that is similar to PCR in many ways but does not require a thermal cycler and is therefore more suitable for in-field use.

Quidel will fund and jointly develop with BioHelix assays to rapidly detect infectious pathogens in a non-instrumented, handheld format using BioHelix's isothermal amplification technology.

Pages

New results from the NASA Twins Study indicate that the immune system may rev up when in space, the Washington Post reports.

Kelvin Droegemeier, the new science advisor, spoke at the American Association for the Advancement of Science meeting, Geekwire reports.

In PNAS this week: whole-genome assembly for the white shark, paper-based microfluidic method for detecting the malaria parasite, and more.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.